4.5 Article

TCIRG1-Associated Congenital Neutropenia

Journal

HUMAN MUTATION
Volume 35, Issue 7, Pages 824-827

Publisher

WILEY-BLACKWELL
DOI: 10.1002/humu.22563

Keywords

TCIRG1; congenital neutropenia; SCN; V-ATPase

Funding

  1. NIH [1U54HG006493]
  2. NIH/NIAID [5R 24AI049393-09, T32 GM007454]
  3. Washington State Life Sciences for University of Washington Northwest Institute of Genetic Medicine [2065508]

Ask authors/readers for more resources

Severe congenital neutropenia (SCN) is a rare hematopoietic disorder, with estimated incidence of 1 in 200,000 individuals of European descent, many cases of which are inherited in an autosomal dominant pattern. Despite the fact that several causal genes have been identified, the genetic basis for >30% of cases remains unknown. We report a five-generation family segregating a novel single nucleotide variant (SNV) in TCIRG1. There is perfect cosegregation of the SNV with congenital neutropenia in this family; all 11 affected, but none of the unaffected, individuals carry this novel SNV. Western blot analysis show reduced levels of TCIRG1 protein in affected individuals, compared to healthy controls. Two unrelated patients with SCN, identified by independent investigators, are heterozygous for different, rare, highly conserved, coding variants in TCIRG1.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available